MAY 14, 2020 6:41 AM PDT

New Tech Has Its AI on Brain Tumors

WRITTEN BY: Tara Fernandez

 

A collaboration across 29 research and healthcare agencies is putting together the world’s largest brain tumor dataset to answer the question: could artificial intelligence (AI) detect brain tumors better than doctors can?

The project, led by Intel and Penn Medicine will receive $1.2 million in grant funding over 3 years from the National Institutes of Health (NIH). Diagnostic technologies driven by AI and machine learning have already proven their worth in accurately detecting skin, breast and lung cancers. Lessons learned from these platforms are informing strategies for the next wave of AI diagnostics. Fundamentally, the key to establishing a robust diagnostic platform, with minimal false positives and negatives, is to feed AI enough validated data for it to teach itself the difference between malignant and benign tissues.

Patient data, however, is extremely sensitive and subject to stringent privacy and security measures — making it a challenge for developers to access sufficiently large and robust datasets. To address this, the team is using a method known as federated learning, which uses encrypted data transfer and decentralized servers to securely channell patient data from all the participating centers.

 

 

Over 23,000 adults and 3,500 children in the United States will be diagnosed with a brain tumor this year. In brain cancer, masses of abnormal cells, which can be either cancerous or benign, begin to grow. Both can cause severe neurological conditions due to the build up of pressure on sensitive brain tissue. Headaches, blurred vision and memory loss are among some of the early symptoms of this cancer of the nervous system. Although in many cases, the early stages can be completely asymptomatic, with brain tumors being picked up by chance — for example, when a patient gets a scan for a traumatic head injury.

Advanced imaging techniques are allowing physicians to scan the brain with unprecedented clarity and are a source of rich, high-quality data from which to train AI. Rather than replacing human doctors, AI-assisted diagnostics could very well play a central role in physicians' toolbox, giving them the power of insights from big datasets to catch tumors in their patients earlier.


Source: Engaget.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 15, 2020
Neuroscience
Hearing Test Can Predict Autism in Newborns
NOV 15, 2020
Hearing Test Can Predict Autism in Newborns
For some time now, researchers have been aware that children and adults with autism tend to have different sensory syste ...
NOV 18, 2020
Clinical & Molecular DX
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
NOV 18, 2020
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
Researchers have identified a new prognostic biomarker for Guillain-Barré syndrome (GBS), a rare autoimmune disor ...
DEC 23, 2020
Clinical & Molecular DX
Smartphone Device Uses CRISPR to Check for COVID
DEC 23, 2020
Smartphone Device Uses CRISPR to Check for COVID
Quick, portable, and ultrasensitive—a new smartphone test for COVID-19 checks all the boxes needed to get a handle ...
DEC 24, 2020
Clinical & Molecular DX
Feeling Unmotivated? It Could Be Dementia.
DEC 24, 2020
Feeling Unmotivated? It Could Be Dementia.
Apathy, characterized by a pronounced lack of enthusiasm, motivation, or interest, is a predictor of the future onset of ...
JAN 26, 2021
Genetics & Genomics
Why Only Some People With a Rare Mutation Get a Heart Condition
JAN 26, 2021
Why Only Some People With a Rare Mutation Get a Heart Condition
Scientists have found a way to explain why a heart condition called hypertrophic cardiomyopathy (HCM) can be so differen ...
FEB 25, 2021
Clinical & Molecular DX
A Better Way to Triage COVID Patients
FEB 25, 2021
A Better Way to Triage COVID Patients
Australian researchers have developed a COVID-19 triaging tool that serves as a crystal ball for healthcare workers. Onc ...
Loading Comments...